EP1758610
Aðferðir til meðferðar á krabbameini þar sem að notað er IL-21 og einklóna mótefnismeðferð
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
20.5.2005EP published:
4.7.2012EP application number:
05756320.7
EP translation filed:
24.8.2012Grant published:
15.9.2012EPO information:
European Patent Register
Max expiry date:
19.5.2025Expiry date:
19.5.2016
Title:
METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY
Timeline
Today
20.5.2005EP application
4.7.2012EP Publication
24.8.2012Translation submitted
15.9.2012Registration published
19.5.2016Expires
Owner
Name:
ZymoGenetics, Inc.Address:
1201 Eastlake Avenue East, 98102, Seattle, WA, US
Inventor
Name:
KINDSVOGEL, Wayne, R.Address:
Seattle, WA, US
Name:
HUGHES, Steven, D.Address:
Kenmore, WA, US
Name:
HOLLY, Richard, D.Address:
Seattle, WA, US
Name:
CLEGG, Christopher, H.Address:
Seattle, WA, US
Name:
FOSTER, Donald, C.Address:
Lake Forest Park, WA, US
Name:
JOHNSON, Rebecca, A.Address:
Seattle, WA, US
Name:
HEIPEL, Mark, D.Address:
Seattle, WA, US
Name:
SIVAKUMAR, Pallavur, V.Address:
Seattle, WA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
572973 PDate:
20.5.2004Country:
US
Number:
635380 PDate:
10.12.2004Country:
US
Number:
671281 PDate:
14.4.2005Country:
US
Number:
680447 PDate:
12.5.2005Country:
US
Classification
Categories:
A61K 39/395, A61P 35/00, A61K 38/20
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 9.4.2013
Expires: 19.5.2014
Payer: Árnason Faktor
Number: 10
Paid: 9.4.2014
Expires: 19.5.2015
Payer: Árnason Faktor
Number: 11
Paid: 9.4.2015
Expires: 19.5.2016
Payer: Árnason Faktor